National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.
CanSpeak, Sydney, New South Wales, Australia.
J Cancer Surviv. 2022 Apr;16(2):461-473. doi: 10.1007/s11764-021-01041-7. Epub 2021 May 18.
To quantify the relationship of cancer diagnosis to workforce participation in Australia, according to cancer type, clinical features and personal characteristics.
Questionnaire data (2006-2009) from participants aged 45-64 years (n=163,556) from the population-based 45 and Up Study (n=267,153) in New South Wales, Australia, were linked to cancer registrations to ascertain cancer diagnoses up to enrolment. Modified Poisson regression estimated age- and sex-adjusted prevalence ratios (PRs) for non-participation in the paid workforce-in participants with cancer (n=8,333) versus without (n=155,223), for 13 cancer types.
Overall, 42% of cancer survivors and 29% of people without cancer were out of the workforce (PR=1.18; 95%CI=1.15-1.21). Workforce non-participation varied substantively by cancer type, being greatest for multiple myeloma (1.83; 1.53-2.18), oesophageal (1.70; 1.13-2.58) and lung cancer (1.68; 1.45-1.93) and moderate for colorectal (1.23; 1.15-1.33), breast (1.11; 1.06-1.16) and prostate cancer (1.06; 0.99-1.13). Long-term survivors, 5 or more years post-diagnosis, had 12% (7-16%) greater non-participation than people without cancer, and non-participation was greater with recent diagnosis, treatment or advanced stage. Physical disability contributed substantively to reduced workforce participation, regardless of cancer diagnosis.
Cancer survivors aged 45-64 continue to participate in the workforce. However, participation is lower than in people without cancer, varying by cancer type, and is reduced particularly around the time of diagnosis and treatment and with advanced disease.
While many cancer survivors continue with paid work, participation is reduced. Workforce retention support should be tailored to survivor preferences, cancer type and cancer journey stage.
根据癌症类型、临床特征和个人特征，量化澳大利亚癌症诊断与劳动力参与之间的关系。
利用澳大利亚新南威尔士州基于人群的 45 岁及以上研究（n=267153）中年龄在 45-64 岁（n=163556）参与者的 2006-2009 年问卷调查数据（n=163556），将其与癌症登记数据相联系，以确定参与者在入组前的癌症诊断情况。采用修正泊松回归估计了癌症患者（n=8333）和无癌症患者（n=155223）中 13 种癌症类型的非劳动力参与（即有薪工作）的年龄和性别调整患病率比（PR）。
总体而言，42%的癌症幸存者和 29%的无癌症人群没有参与劳动力市场（PR=1.18；95%CI=1.15-1.21）。不同癌症类型的劳动力参与情况存在实质性差异，多发性骨髓瘤（1.83；1.53-2.18）、食道癌（1.70；1.13-2.58）和肺癌（1.68；1.45-1.93）的非劳动力参与率最高，结直肠癌（1.23；1.15-1.33）、乳腺癌（1.11；1.06-1.16）和前列腺癌（1.06；0.99-1.13）的非劳动力参与率适中。诊断后 5 年或以上的长期幸存者的非劳动力参与率比无癌症人群高 12%（7-16%），且最近诊断、治疗或晚期癌症的非劳动力参与率更高。无论是否患有癌症，身体残疾都大大降低了劳动力参与率。
45-64 岁的癌症幸存者仍继续参与劳动力市场。然而，与无癌症人群相比，参与率较低，且因癌症类型而异，尤其是在诊断和治疗期间以及疾病晚期。
尽管许多癌症幸存者继续从事有薪工作，但参与率有所降低。劳动力保留支持应根据幸存者的偏好、癌症类型和癌症进展阶段进行调整。
